Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
100
38
7
53
47
38
Croissance des revenus (H/H)
186%
443%
-87%
13%
24%
-17%
Coût des ventes
49
21
6
36
32
25
Bénéfice brut
50
17
1
16
15
12
Vente, Général et Administration
60
45
11
24
27
10
Recherche et développement
16
5
3
7
0
--
Frais d'exploitation
90
50
18
36
31
13
Autres revenus (charges) non opérationnels
0
2
-1
1
0
1
Bénéfice avant impôts
-49
-28
-32
-19
-16
-1
Charge d'impôt sur le revenu
-1
0
0
1
0
0
Bénéfice net
-59
-26
-31
-21
-15
-1
Croissance du bénéfice net
18%
-16%
48%
40%
1,400%
--
Actions en circulation (diluées)
237.81
135.56
57.03
50.08
48
38.33
Variation des actions (H-H)
46%
138%
14%
4%
25%
-53%
EPS (dilué)
-0.24
-0.19
-0.56
-0.42
-0.33
-0.03
Croissance du EPS
-20%
-66%
34%
27%
1,000%
--
Flux de trésorerie libre
-25
-23
-10
-9
-9
3
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
50%
44.73%
14.28%
30.18%
31.91%
31.57%
Marge opérationnelle
-39%
-86.84%
-228.57%
-35.84%
-34.04%
0%
Marge bénéficiaire
-59%
-68.42%
-442.85%
-39.62%
-31.91%
-2.63%
Marge du flux de trésorerie libre
-25%
-60.52%
-142.85%
-16.98%
-19.14%
7.89%
EBITDA
-23
-26
-14
-15
-13
2
Marge EBITDA
-23%
-68.42%
-200%
-28.3%
-27.65%
5.26%
D&A pour le résultat opérationnel
16
7
2
4
3
2
EBIT
-39
-33
-16
-19
-16
0
Marge EBIT
-39%
-86.84%
-228.57%
-35.84%
-34.04%
0%
Taux d'imposition effectif
2.04%
0%
0%
-5.26%
0%
0%
Statistiques clés
Clôture préc.
$0.52
Prix d'ouverture
$0.52
Plage de la journée
$0.4872 - $0.52
Plage de 52 semaines
$0.4872 - $1.41
Volume
28.9K
Volume moyen
140.4K
BPA (TTM)
-0.17
Rendement en dividend
--
Capitalisation boursière
$135.6M
Qu’est-ce que HealWELL AI Inc. ?
HealWELL AI, Inc. is a health care technology company, which focuses on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. The company is headquartered in Toronto, Ontario and currently employs 350 full-time employees. The company went IPO on 2007-04-25. The Company, using its own proprietary technology, is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases. The firm's segments include Clinical Research and Patient services, AI and Data sciences and Healthcare Software. The Clinical Research and Patient Services segment includes clinical research contracts and medical consultations provided through the Company's MCI Polyclinic Group Inc. and BioPharma subsidiaries in Ontario. The AI and Data Sciences segment includes integration of advanced AI and data science technologies in healthcare through its Khure Health Inc. and Pentavere and Mutuo subsidiaries. The Healthcare Software segment includes Intrahealth and Versource healthcare software-as-a-service.